| Drug Name: | Aprindine (37640-71-4) |
|---|---|
| PubChem ID: | 2218 |
| SMILES: | CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3 |
| InchiKey: | NZLBHDRPUJLHCE-UHFFFAOYSA-N |
| Therapeutic Category: | Anti-Arrhythmia Agents, Cardiovascular Agents, Membrane Transport Modulators, Sodium Channel Blockers, Voltage-Gated Sodium Channel Blockers |
| Molecular Weight (dalton) | : | 322.496 |
| LogP | : | 4.3923 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 6.48 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Agranulocytosis | Histamine H1 receptor (P35367) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
| Bone Marrow Disorder | Histamine H1 receptor (P35367) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
| Extrapyramidal Disorder | Histamine H1 receptor (P35367) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category